Bottom line
POSKX vs CANC: the short answer
POSKX (PRIMECAP Odyssey Stock Fund) and CANC (Tema Oncology ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.
But POSKX is far broader, holding 149 positions to 57 for CANC, so beyond the top names it adds exposure CANC doesn't have.
POSKX is cheaper at 0.67% vs 0.75% — a difference of $8.00 a year per $10,000 invested.
Over one year, CANC returned +42.8% vs +25.6% for POSKX.
Updated Nov 19, 2026
POSKX vs CANC side by side
| POSKX | CANC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Primecap Odyssey | Innovator |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.67% | 0.75% |
| Annual cost per $10k | $67 | $75 |
| 10-yr cost on $10k (prospectus) | $835 | $1,168 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +25.6% | +42.8% |
| 5-yr return (annualized) | +13.9% | — |
| 10-yr return (annualized) | +13.5% | — |
| Best quarter | +17.4% | +21.1% |
| Worst quarter | −25.7% | −12.0% |
| Net assets (fund) | $4.6B | $176.1M |
| Number of holdings | 149 | 57 |
| Portfolio turnover | 9% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | POSKX | CANC | Difference |
|---|---|---|---|
| 2025 | +25.6% | +42.8% | −17.2% |
| 2024 | +12.8% | −5.3% | +18.2% |
Source: Fund prospectus bar charts
Holdings overlap
4 of POSKX's top 25 holdings also appear in CANC's top 25.
| Holding | POSKX | CANC |
|---|---|---|
| Eli Lilly & Co | 5.54% | 4.82% |
| AstraZeneca PLC | 3.43% | 3.54% |
| Bristol-Myers Squibb Co | 1.75% | 3.30% |
| Amgen Inc | 1.60% | 2.11% |
Source: SEC Form N-PORT
POSKX top 10
- Intel Corp — 7.41%
- Eli Lilly & Co — 5.54%
- AstraZeneca PLC — 3.43%
- Flex Ltd — 3.34%
- KLA Corp — 2.75%
- Siemens AG — 2.53%
- Ross Stores Inc — 2.42%
- Microsoft Corp — 2.38%
- Biogen Inc — 2.34%
- FedEx Corp — 1.85%
CANC top 10
- Revolution Medicines Inc — 7.73%
- Eli Lilly & Co — 4.82%
- Roche Holding AG — 4.21%
- Cogent Biosciences Inc — 4.10%
- Novartis AG — 4.03%
- Immunome Inc — 3.91%
- Celcuity Inc — 3.58%
- Merck & Co Inc — 3.57%
- AstraZeneca PLC — 3.54%
- Nuvalent Inc — 3.37%
FAQ
What is the difference between POSKX and CANC?
Which is cheaper, POSKX or CANC?
Should I own both POSKX and CANC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.